The novel 1 OP-aziridinylestr-4-ene-3.17-diones 17 and 18 and the corresponding 1 OP-aziridinyl-17Phydroxyestr-4-en-3-ones 19 and 20 have been synthesized from the 19-oximino-1 9-methyl intermediate 12b. The key reaction was the conversion of the 19-oxime 12b into the diastereoisomeric 10P-aziridines 13 and 1 4 by lithium aluminium hydride (LAH). Compounds 17-20 are powerful and stereoselective inhibitors of human placental microsomal aromatase. The most potent compound was 17 (Ki = 3.4 nmol dm-3). The 19R-isomers17 and 19 are more effective than the corresponding 19sisomers 18 and 20, respectively. Unlike the corresponding 1 OD-oxiranes and -thiiranes which are classical competitive inhibitors, the (1 9R)-aziridines 17 and 19 appear to be slow-binding inhibitors. Spectroscopic studies with microsomal aromatase preparations indicate that the inhibition process involves binding of aziridine nitrogen to the heme-iron of the enzyme.* For full details of the CCDC deposition scheme see 'Instructions for Authors,' J. Chem. SOC., Perkin Trans. I , 1993, Issue 1.